Many fixed-dose drug combinations in India lack central regulatory approval

Fixed-dose drug combinations which have not received central regulatory approval are sold in substantial numbers in India -- despite concerns over the safety and efficacy of these combinations -- according to new research.

from Today's Healthcare News -- ScienceDaily http://ift.tt/1zYWs6y